Merus N.V (NASDAQ: MRUS) on Tuesday, soared 4.91% from the previous trading day, before settling in for the closing price of $42.80. Within the past 52 weeks, MRUS’s price has moved between $24.82 and $61.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 7.00%. The company achieved an average annual earnings per share of -27.62%. With a float of $58.58 million, this company’s outstanding shares have now reached $68.43 million.
The extent of productivity of a business whose workforce counts for 229 workers is very important to gauge. In terms of profitability, gross margin is -4.25%, operating margin of -642.76%, and the pretax margin is -659.93%.
Merus N.V (MRUS) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Merus N.V is 14.43%, while institutional ownership is 90.63%. The most recent insider transaction that took place on Aug 21 ’24, was worth 135,000. In this transaction VP Controller, PAO of this company sold 2,500 shares at a rate of $54.00, taking the stock ownership to the 7,002 shares. Before that another transaction happened on Aug 20 ’24, when Company’s VP Controller, PAO sold 2,500 for $54.00, making the entire transaction worth $135,000. This insider now owns 7,002 shares in total.
Merus N.V (MRUS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.30% during the next five years compared to -18.50% drop over the previous five years of trading.
Merus N.V (NASDAQ: MRUS) Trading Performance Indicators
Merus N.V (MRUS) is currently performing well based on its current performance indicators. A quick ratio of 8.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 85.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.91, a number that is poised to hit -0.96 in the next quarter and is forecasted to reach -3.87 in one year’s time.
Technical Analysis of Merus N.V (MRUS)
The latest stats from [Merus N.V, MRUS] show that its last 5-days average volume of 0.54 million was inferior to 0.68 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.33%. Additionally, its Average True Range was 2.20.
During the past 100 days, Merus N.V’s (MRUS) raw stochastic average was set at 25.20%, which indicates a significant decrease from 46.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.93% in the past 14 days, which was higher than the 36.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.78, while its 200-day Moving Average is $49.56. Now, the first resistance to watch is $45.73. This is followed by the second major resistance level at $46.55. The third major resistance level sits at $48.06. If the price goes on to break the first support level at $43.39, it is likely to go to the next support level at $41.88. The third support level lies at $41.05 if the price breaches the second support level.
Merus N.V (NASDAQ: MRUS) Key Stats
Market capitalization of the company is 3.07 billion based on 68,464K outstanding shares. Right now, sales total 43,950 K and income totals -154,940 K. The company made 11,770 K in profit during its latest quarter, and -99,910 K in sales during its previous quarter.
